Chung Jane 4
4 · SUTRO BIOPHARMA, INC. · Filed Aug 26, 2025
Insider Transaction Report
Form 4
Chung Jane
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2025-08-09$0.80/sh−6,708$5,366→ 110,350 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-08-09−18,750→ 0 totalExp: 2025-08-09→ Common Stock (18,750 underlying) - Exercise/Conversion
Common Stock
2025-08-09+18,750→ 117,058 total
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vested or vest as to 1/4th of the total award annually beginning on August 9, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.